URO-1 is an emerging medical device company developing disposable products for office procedures in urogynecology and urology. Its inaugural product, the Repris™ Bladder Injection System, has just been cleared to market by the US FDA. It is specifically designed to help reduce complications following onabotulinumtoxinA treatment for overactive bladder (OAB) in women. Repris™ features the unique Re4m™ memory cannula platform and the Rely™ "no look" self-metering syringe. 


Additional products are currently in late-stage development.


URO-1 Inc.

Wake Forest Innovation Quarter

101 North Chestnut, Suite 101

Winston-Salem, NC 27101

Contact Us

© 2018 URO-1 Inc. URO-1, Repris, Re4m, Rely and their respective logos are trademarks of URO-1 Inc. All other trademarks are the property of their respective holders. Patents pending.

PN 60004 Rev B